Operations Team

Anthony English
Chief Executive OfficerDuring his PhD research in behavioral neuroscience, Anthony conceptualized Biosyft to help scientists like himself get more informative behavioral data with less time and effort. As BioSyft’s Chief Executive Officer, Anthony leads decision making and strategic vision and fosters and maintains relationships with advisors, funders, collaborators, and media.

Niall Curley
Chief Financial Officer & Chief Operating OfficerWith 7 years of experience working with contract research organizations and 3 years of MBA training, Niall is uniquely familiar with the clinical trial landscape and its customers. As BioSyft’s Chief Financial Officer and Chief Operating Officer, Niall oversees financial strategy, supervises overall operations, and manages risk.

Victoria Corbit, PhD
Chief Scientific OfficerWith her 10 years of hands-on experience collecting, analyzing, and interpreting rodent behavioral data, Dr. Corbit brings a perspective as a researcher as well as a proven track record of receiving research funding. As Chief Scientific Officer, Victoria oversees research and development, manages scientific collaborations and regulatory compliance, and ensures scientific integrity and innovation.

Gunn Chun
Software EngineerThrough his work at various start-up companies and labs, Gunn has developed expertise in both data analysis and pipeline development. As a Software Engineer at BioSyft, Gunn leverages these skills to create robust, research-driven applications that bridge the gap between academic insight and production systems.

Amardeep Singh
Software EngineerAmardeep is a trained chemical engineering professional with a wide variety of expertise in advanced manufacturing, biotechnology, sustainability and, AI software development. As a Software Engineer at BioSyft, Amardeep’s expertise lies in algorithmic research and development aimed at producing models that enhance the team’s understanding of animal interactions.
Scientific Advisors

Michael Bruchas, PhD
A leader in the field of behavioral neuroscience and cutting-edge research technologies, Dr. Michael Bruchas has previous entrepreneurial experience co-founding NeuroLux.

Nephi Stella, PhD
As a seasoned molecular and cell biologist in the cannabinoid field, Dr. Nephi Stella has previously established a therapeutics company (Stella Therapeutics) and is continuing his entrepreneurial journey.

Benjamin Land, PhD
An expert in animal behavior and behavioral research techniques, Dr. Benjamin Land provides a unique perspective on the execution of BioSyft technologies.

